Results 21 to 30 of about 46,956 (278)

Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice. [PDF]

open access: yesPLoS Genetics, 2013
Impaired mitochondrial oxidative phosphorylation (OXPHOS) has been proposed as an etiological mechanism underlying insulin resistance. However, the initiating organ of OXPHOS dysfunction during the development of systemic insulin resistance has yet to be
Min Jeong Ryu   +20 more
doaj   +4 more sources

Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications

open access: yesSeminars in Cancer Biology, 2022
Oxidative phosphorylation (OXPHOS) takes place in mitochondria and is the process whereby cells use carbon fuels and oxygen to generate ATP. Formerly OXPHOS was thought to be reduced in tumours and that glycolysis was the critical pathway for generation ...
John Greene   +2 more
exaly   +3 more sources

Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer

open access: yesCell Reports Medicine, 2020
International audienceHighlights d Pancreatic ductal adenocarcinoma (PDAC) displays OXPHOS heterogeneity d High OXPHOS PDAC tumors are enriched in mitochondrial respiratory complex I d Complex I inhibitor phenformin synergizes with chemotherapy in high ...
Gabriela Reyes-Castellanos   +2 more
exaly   +2 more sources

Bayesian classification of OXPHOS deficient skeletal myofibres [PDF]

open access: yesPLOS Computational Biology
Mitochondria are organelles in most human cells which release the energy required for cells to function. Oxidative phosphorylation (OXPHOS) is a key biochemical process within mitochondria required for energy production and requires a range of proteins ...
Golightly, Andrew
core   +6 more sources

Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases [PDF]

open access: yesJournal of Cell Biology, 2017
Mitochondria participate in essential processes in the nervous system such as energy and intermediate metabolism, calcium homeostasis, and apoptosis. Major neurodegenerative diseases are characterized pathologically by accumulation of misfolded proteins ...
Giovanni Manfredi, Hibiki Kawamata
core   +3 more sources

Mitoribosomal regulation of OXPHOS biogenesis in plants [PDF]

open access: yesFrontiers in Plant Science, 2014
The ribosome filter hypothesis posits that ribosomes are not simple non-selective translation machines but may also function as regulatory elements in protein synthesis. Recent data supporting ribosomal filtering come from plant mitochondria where it has
Malgorzata eKwasniak   +3 more
core   +4 more sources

Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption [PDF]

open access: yesPharmaceuticals
Background/Objectives: Mitochondrial Oxidative Phosphorylation (OXPHOS) is a critical metabolic dependency in many cancers. Targeting OXPHOS through Leucine-Rich PPR Motif-Containing Protein (LRPPRC) degrader-mediated OXPHOS Complex Biogenesis Inhibition
Jing Chen   +7 more
doaj   +2 more sources

OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer

open access: yesRedox Biology
The hypothesis of a significant shift from oxidative phosphorylation (OXPHOS) to glycolysis in a number of solid tumors has been dominant for many years.
Cemile Uslu, Eda Kapan, Alex Lyakhovich
doaj   +2 more sources

Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance

open access: yesRedox Biology, 2019
The ability to selectively eradicate oncogene-addicted tumors while reducing systemic toxicity has endeared targeted therapies as a treatment strategy. Nevertheless, development of acquired resistance limits the benefits and durability of such a regime ...
Jie Qing Eu   +2 more
exaly   +3 more sources

OXPHOS-targeting drugs in oncology: new perspectives

open access: yesExpert Opinion on Therapeutic Targets, 2023
International audienceIntroductionDrugs targeting mitochondria are emerging as promising antitumor therapeutics in preclinical models. However, a few of these drugs have shown clinical toxicity. Developing mitochondria-targeted modified natural compounds
Hardy, Micael   +7 more
core   +4 more sources

Home - About - Disclaimer - Privacy